Mycophenolsäure (Mycophenolic Acid)

The drug inhibits the enzyme inosine monophosphate dehydrogenase, which is crucial for the synthesis of guanosine nucleotides in lymphocytes. By blocking this pathway, Mycophenolic Acid reduces the proliferation of T and B cells, providing targeted immunosuppression without broadly affecting other cell types.

The specific dose of Mycophenolic Acid is determined by the prescribing clinician based on the patient’s condition, weight, renal function, and other individual factors. Healthcare professionals tailor the regimen to achieve optimal immunosuppression while minimizing adverse effects.

The safety of Mycophenolic Acid in pregnancy and lactation is not well established, and it is generally avoided unless the potential benefits outweigh the risks. Women of childbearing potential should use effective contraception, and breastfeeding decisions should be made in consultation with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with calcineurin inhibitors such as cyclosporine or tacrolimus, Mycophenolic Acid offers a different mechanism by targeting nucleotide synthesis rather than calcineurin signaling. It is often used in combination regimens to provide synergistic immunosuppression while potentially reducing the dose‑related toxicities of other agents.

Mycophenolic Acid should be stored at ambient temperature, preferably below 25 °C. Keep the medication in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The drug is taken orally, usually in tablet or capsule form, and should be swallowed whole with water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort. Follow the prescribing clinician’s instructions for timing and dosing.

Serious risks include severe infections due to immunosuppression, bone marrow suppression leading to pancytopenia, progressive renal dysfunction, and rare neurological complications such as reversible posterior leukoencephalopathy syndrome. Patients should be monitored regularly for these potential complications.

Mycophenolic Acid is contraindicated in patients with known hypersensitivity to the drug or its components, those with severe uncontrolled infections, and individuals who are pregnant unless the benefits clearly outweigh the risks. Caution is also advised for patients with significant hepatic or renal impairment.